Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
A look into the FDA’s rigorous 2023 drug approval process, including a record number of new medicines and notable rejections. Understanding these trends is essential for anticipating future treatment landscapes.
Endocrinology, Diabetes, Metabolism January 8th 2024
Cleveland Clinic Journal of Medicine
Uncover the often-overlooked complication of diabetes, diabetic cheiroarthropathy, and its potential links to microvascular complications.
Endocrinology, Diabetes, Metabolism January 4th 2024
Clinical Advisor
New reports and studies are raising concerns about the gastrointestinal safety of semaglutide-containing medications; clinicians are advised to exercise caution and monitor patients for symptoms of gastroparesis.
Endocrinology, Diabetes, Metabolism October 4th 2023
Endocrinology Advisor
Discover how cinnamon supplementation could serve as a promising adjunctive treatment for improving glycemic control in T2D and PCOS patients. Further research is needed to standardize dosing and types.
Endocrinology, Diabetes, Metabolism September 7th 2023
MedTech Dive
Dexcom’s innovative continuous glucose monitor is set to transform the management of type 2 diabetes for non-insulin users in the US, offering personalized insights to help them optimize their lifestyle choices while minimizing the need for insulin.
Endocrinology, Diabetes, Metabolism July 6th 2023
SingleCare
Explore how the age-old remedy of apple cider vinegar might offer modern benefits for men’s health, including weight management, blood sugar control, and cholesterol reduction.
All Specialties June 21st 2023